Abstract:Objective: This study aims to employ bioinformatics methods and single-cell sequencing technology to identify and analyze characteristic genes of the immune microenvironment in colorectal cancer (CRC), deepening the understanding of CRC pathogenesis and providing new perspectives and potential targets for personalized immunotherapy. Methods: We used single-sample gene set enrichment analysis (ssGSEA) to identify common differentially infiltrating immune cells from the TCGA and GEO databases. Employing two machine learning algorithms, we selected key immune cell subgroups with significant impact in normal and CRC tissues, playing vital roles in the CRC immune microenvironment. We then applied weighted gene co-expression network analysis (WGCNA) in the GEO and TCGA cohorts to identify gene modules significantly related to seven immune cell types. Using the single-cell sequencing dataset GSE225857, we extracted differentially expressed genes within key immune cell subgroups and integrated them with important WGCNA modules to identify key immune predictive genes. An immune-related analysis of these key genes was conducted to explore their potential as characteristic genes of the CRC immune microenvironment. Results: Through ssGSEA and the selection of 28 immune infiltration scores by two machine learning algorithms, we identified seven key immune cells impacting the CRC immune microenvironment: activated B cells, activated CD4 T cells, effector memory CD4 T cells, mast cells, memory B cells, bright natural killer cells, and natural killer T cells. Combined single-cell transcriptomics and WGCNA analysis revealed that Regulator of G Protein Signaling 1 (RGS1) varied in expression among different immune cell subtypes and was included in the WGCNA immune-related module. Immune-related analysis of RGS1 indicated its high expression in immune cell subtypes, along with high tumor microenvironment (TME) scores and high immune function scores. Furthermore, RGS1 expression correlated with various immune function scores (such as Type II IFN Response, APC co-inhibition, MHC class I), indicating its multifaceted role in the CRC immune microenvironment. Conclusion: This study identified key immune cell subgroups impacting the CRC immune microenvironment, with RGS1 emerging as a significant regulatory factor. RGS1 may play a critical role in modulating immune responses, influencing tumor immune evasion mechanisms, and drug sensitivity. Therefore, targeting RGS1 may provide a new strategic direction for CRC immunotherapy.

Regulator of G protein signaling 16 restrains apoptosis in colorectal cancer through disrupting TRAF6-TAB2-TAK1-JNK/p38 MAPK signaling

Efficacy of Rigosertib, a Small Molecular RAS Signaling Disrupter for the Treatment of KRAS-mutant Colorectal Cancer

Rigosertib Promotes Anti-Tumor Immunity Via Autophagic Degradation of PD-L1 in Colorectal Cancer Cells

Diverse Ras-related GTPase DIRAS2, downregulated by PSMD2 in a proteasome-mediated way, inhibits colorectal cancer proliferation by blocking NF-B signaling

TRAF6 Inhibits Colorectal Cancer Metastasis Through Regulating Selective Autophagic CTNNB1/β-catenin Degradation and is Targeted for GSK3B/GSK3β-mediated Phosphorylation and Degradation.

Data from REGγ Controls Hippo Signaling and Reciprocal NF-κB–YAP Regulation to Promote Colon Cancer

Regulators of G-Protein Signaling (RGS) in Sporadic and Colitis-Associated Colorectal Cancer

G-Protein Signaling Protein-17 (RGS17) is Upregulated and Promotes Tumor Growth and Migration in Human Colorectal Carcinoma.

RPL36A activates ERK pathway and promotes colorectal cancer growth

Targeting Regulator of G Protein Signaling 1 in Tumor-Specific T Cells Enhances Their Trafficking to Breast Cancer

DR6 Augments Colorectal Cancer Cell Growth, Invasion, and Stemness by Activating AKT/NF-κB Pathway

The Role of RAB GTPases and Its Potential in Predicting Immunotherapy Response and Prognosis in Colorectal Cancer

Regulator of G Protein Signaling 1 Trastuzumab Resistance and Malignant Behaviors of Gastric Cancer Cells by Regulating G alpha q Signaling and Activating the MEK/ERK Pathway

Inhibition of JAK1, 2/STAT3 Signaling Induces Apoptosis, Cell Cycle Arrest, and Reduces Tumor Cell Invasion in Colorectal Cancer Cells

Regulator of G Protein Signaling 1 Trastuzumab Resistance and Malignant Behaviors of Gastric Cancer Cells by Regulating Gq Signaling and Activating the MEK/ERK Pathway

Targeting the JAK-STAT pathway in colorectal cancer: mechanisms, clinical implications, and therapeutic potential

GPR176 Promotes Cancer Progression by Interacting with G Protein GNAS to Restrain Cell Mitophagy in Colorectal Cancer

ZG16 regulates PD-L1 expression and promotes local immunity in colon cancer

Identification of Key Genes in the Colorectal Cancer Immune Microenvironment Through Integrated Analysis of Immune Infiltration Algorithms and Single-Cell Transcriptomics

RGS6 Suppresses TGF-β-induced Epithelial–mesenchymal Transition in Non-Small Cell Lung Cancers Via a Novel Mechanism Dependent on Its Interaction with SMAD4

RGS20 promotes non-small cell lung carcinoma proliferation via autophagy activation and inhibition of the PKA-Hippo signaling pathway